1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Ebola Viral Infections Global Clinical Trials Review, H2, 2014

Ebola Viral Infections Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Ebola Viral Infections Global Clinical Trials Review, H2, 2014" provides data on the Ebola Viral Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ebola Viral Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ebola Viral Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Ebola Viral Infections Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 5
Ebola Viral Infections 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Ebola Viral Infections to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Ebola Viral Infections to Infectious Disease Clinical Trials 16
Clinical Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Ebola Viral Infections 20
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Ebola Viral Infections Therapeutics Clinical Trials 26
Prominent Drugs 27
Latest Clinical Trials News on Ebola Viral Infections 28
Sep 23, 2014: Tekmira Joins International Consortium to Conduct Clinical Trials of Ebola Virus Therapeutics in West Africa 28
Aug 28, 2014: Ebola vaccine trials fast-tracked by international consortium 28
Aug 25, 2014: Ebola Vaccine Using Immunovaccine's DepoVax Proves Highly Efficacious in Non-Human Primate Study 30
Jul 21, 2014: Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold 30
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Tekmira Pharmaceuticals Corp. 32
Clinical Trial Overview of Tekmira Pharmaceuticals Corp. 32
Sarepta Therapeutics, Inc. 33
Clinical Trial Overview of Sarepta Therapeutics, Inc. 33
GlaxoSmithKline plc 34
Clinical Trial Overview of GlaxoSmithKline plc 34
Inovio Pharmaceuticals, Inc. 35
Clinical Trial Overview of Inovio Pharmaceuticals, Inc. 35
Chimerix, Inc. 36
Clinical Trial Overview of Chimerix, Inc. 36
Clinical Trial Overview of Top Institutes / Government 37
The National Institute of Allergy and Infectious Diseases 37
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 37
Academy of Military Medical Sciences 38
Clinical Trial Overview of Academy of Military Medical Sciences 38
University of Oxford 39
Clinical Trial Overview of University of Oxford 39
Five Key Clinical Profiles 40
Appendix 60
Abbreviations 60
Definitions 60
Research Methodology 61
Secondary Research 61
About GlobalData 62
Contact Us 62
Disclaimer 62
Source 62

List of Tables

Ebola Viral Infections Therapeutics, Global, Clinical Trials by Region, 2014* 6
Ebola Viral Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Ebola Viral Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Ebola Viral Infections Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Ebola Viral Infections Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Ebola Viral Infections Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Ebola Viral Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Ebola Viral Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13
Ebola Viral Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Ebola Viral Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Ebola Viral Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16
Ebola Viral Infections Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Ebola Viral Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Ebola Viral Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Ebola Viral Infections Therapeutics, Global, Suspended Clinical Trials, 2014* 20
Ebola Viral Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014* 21
Ebola Viral Infections Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Ebola Viral Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Ebola Viral Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Ebola Viral Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Ebola Viral Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Ebola Viral Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Ebola Viral Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Tekmira Pharmaceuticals Corp., 2014* 32
Ebola Viral Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarepta Therapeutics, Inc., 2014* 33
Ebola Viral Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 34
Ebola Viral Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Inovio Pharmaceuticals, Inc., 2014* 35
Ebola Viral Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Chimerix, Inc., 2014* 36
Ebola Viral Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 37
Ebola Viral Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Academy of Military Medical Sciences, 2014* 38
Ebola Viral Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 39

List of Figures

Ebola Viral Infections Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Ebola Viral Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Ebola Viral Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Ebola Viral Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 12
Proportion of Ebola Viral Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13
Ebola Viral Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Ebola Viral Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Ebola Viral Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16
Ebola Viral Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Ebola Viral Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Ebola Viral Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Ebola Viral Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Ebola Viral Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Ebola Viral Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Ebola Viral Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 61

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Global Clinical Trials Market

Global Clinical Trials Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) ...

Oncology Devices - Medical Devices Pipeline Assessment, 2016

Oncology Devices - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by GlobalData

Oncology Devices - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Oncology Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.